Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-28 | Q1 FY262026-03-29 | Q4 FY252025-12-28 | Q3 FY252025-09-28 | Q2 FY252025-06-29 | Q1 FY252025-03-30 | Q4 FY242024-12-29 | Q3 FY242024-09-29 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $25.31B | $24.06B | $24.56B | $23.99B | $23.74B | $21.89B | $22.52B | $22.47B |
| Cost of revenue | $8.05B | $8.11B | $7.97B | $7.30B | $7.63B | $7.36B | $7.13B | $6.96B |
| Gross profit | $17.26B | $15.96B | $16.60B | $16.69B | $16.12B | $14.54B | $15.39B | $15.51B |
| Gross margin | 68.2% | 66.3% | 67.6% | 69.6% | 67.9% | 66.4% | 68.3% | 69.0% |
| Research and development | $3.65B | $3.56B | $4.33B | $3.67B | $3.52B | $3.23B | $5.51B | $4.95B |
| Selling, general and administrative | $6.43B | $6.03B | $6.75B | $5.92B | $5.89B | $5.11B | $6.45B | $5.48B |
| Operating expenses | $10.12B | $9.63B | $11.17B | $9.66B | $9.47B | $8.35B | $11.81B | $10.47B |
| Operating income | $7.14B | $6.33B | $5.43B | $7.03B | $6.65B | $6.18B | $3.58B | $5.04B |
| Operating margin | 28.2% | 26.3% | 22.1% | 29.3% | 28.0% | 28.2% | 15.9% | 22.4% |
| EBITDA | $9.13B | $8.36B | $7.52B | $8.87B | $8.65B | $7.97B | $5.33B | $6.92B |
| Interest income | $219.00M | $229.00M | $237.00M | $227.00M | $260.00M | $332.00M | $281.00M | $292.00M |
| Interest expense | −$281.00M | −$272.00M | −$214.00M | −$245.00M | −$308.00M | −$204.00M | −$137.00M | −$193.00M |
| Income before taxes | $6.75B | $5.99B | $4.97B | $7.49B | $6.49B | $13.63B | $3.89B | $3.34B |
| Income taxes | $1.21B | $755.00M | −$150.00M | $2.34B | $954.00M | $2.63B | $456.00M | $644.00M |
| Net income | $5.53B | $5.24B | $5.12B | $5.15B | $5.54B | $11.00B | $3.43B | $2.69B |
| Net margin | 21.9% | 21.8% | 20.8% | 21.5% | 23.3% | 50.2% | 15.2% | 12.0% |
| EPS, basic | $2.30 | $2.17 | $2.12 | $2.14 | $2.30 | $4.57 | $1.43 | $1.12 |
| EPS, diluted | $2.27 | $2.14 | $2.09 | $2.12 | $2.29 | $4.54 | $1.41 | $1.11 |
| Diluted shares | 2.44B | 2.45B | 2.45B | 2.43B | 2.42B | 2.42B | 2.44B | 2.43B |
Figures describe Johnson & Johnson shares, not any token. As of Jul 23, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.